Clinical Trials Browser

Phase 2/3 × NETWORK × Vinorelbine × Clear all

NCT00049660 2012-07-18

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

Phase 2/3 Terminated

Breast Neoplasms